SCHEMBL17562014

SCHEMBL17562014

CCn1c2c(c3c1CCC=C3)CC(Nc1ccnc(Cl)n1)C=C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17562016 0.70 — —
SCHEMBL16229866 0.69 RAC1 (0.39) —
SCHEMBL27820153 0.57 CHRM4 (0.37) —
SCHEMBL17544472 0.57 MALT1 (0.57) —
SCHEMBL27820150 0.56 HRH3 (0.35) —
SCHEMBL27839685 0.55 MALT1 (0.41) —
SCHEMBL1519145 0.55 TLR8 (0.42) —
SCHEMBL28937980 0.55 CRHR1 (0.42) —
SCHEMBL3451280 0.55 CTSK (0.58) —
SCHEMBL29607425 0.55 CRHR1 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278956-B1 Small-molecule inhibitors of Rac1 in metastatic cancer cells UNIVERSITY OF PUERTO RICO (US) 2016-03-08 — — US disclosed
Send feedback